CEPHALOTHIN SODIUM W Drug Patent Profile

Which patents cover Cephalothin Sodium W, and what generic alternatives are available?

Cephalothin Sodium W is a drug marketed by Baxter Hlthcare and is included in two NDAs.

The generic ingredient in CEPHALOTHIN SODIUM W is cephalothin sodium. There are seven drug master file entries for this compound. Additional details are available on the cephalothin sodium profile page.

Summary for CEPHALOTHIN SODIUM W

US Patents:	0
Applicants:	1
NDAs:	2
DailyMed Link:	CEPHALOTHIN SODIUM W at DailyMed

US Patents and Regulatory Information for CEPHALOTHIN SODIUM W

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Baxter Hlthcare	CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER	cephalothin sodium	INJECTABLE;INJECTION	062422-003	Jan 31, 1984		DISCN	No	No
Baxter Hlthcare	CEPHALOTHIN SODIUM W/ SODIUM CHLORIDE IN PLASTIC CONTAINER	cephalothin sodium	INJECTABLE;INJECTION	062422-001	Jan 31, 1984		DISCN	No	No
Baxter Hlthcare	CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER	cephalothin sodium	INJECTABLE;INJECTION	062422-004	Jan 31, 1984		DISCN	No	No
Baxter Hlthcare	CEPHALOTHIN SODIUM W/ SODIUM CHLORIDE IN PLASTIC CONTAINER	cephalothin sodium	INJECTABLE;INJECTION	062422-002	Jan 31, 1984		DISCN	No	No
Baxter Hlthcare	CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER	cephalothin sodium	INJECTABLE;INJECTION	062422-005	Jul 16, 1991		DISCN	No	No
Baxter Hlthcare	CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER	cephalothin sodium	INJECTABLE;INJECTION	062730-001	Mar 5, 1987		DISCN	No	No
Baxter Hlthcare	CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER	cephalothin sodium	INJECTABLE;INJECTION	062730-002	Mar 5, 1987		DISCN	No	No